Point72 Hong Kong LTD Bio Techne Corp Transaction History

Point72 Hong Kong LTD

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $489,359 - $678,684	1,732 Added 38.65%	6,213 $1.76 Million
Q2 2022 Aug 15, 2022	BUY	$322.67 - $449.65 $905,734 - $1.26 Million	2,807 Added 167.68%	4,481 $1.55 Million
Q1 2022 May 16, 2022	BUY	$353.85 - $487.79 $592,344 - $816,560	1,674 New	1,674 $725,000
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $756,296 - $870,549	-1,658 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $737,594 - $893,463	1,658 New	1,658 $803,000
Q1 2021 May 17, 2021	SELL	$314.62 - $411.0 $135,601 - $177,141	-431 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $106,413 - $138,725	431 New	431 $137,000
Q3 2020 Nov 16, 2020	SELL	$232.22 - $282.96 $180,667 - $220,142	-778 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$185.43 - $279.56 $144,264 - $217,497	778 New	778 $205,000
Q4 2019 Feb 14, 2020	SELL	$189.68 - $222.09 $61,266 - $71,735	-323 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$183.56 - $216.72 $13,950 - $16,470	-76 Reduced 19.05%	323 $63,000
Q2 2019 Aug 14, 2019	SELL	$188.72 - $215.43 $50,954 - $58,166	-270 Reduced 40.36%	399 $83,000
Q1 2019 May 15, 2019	BUY	$136.09 - $200.44 $91,044 - $134,094	669 New	669 $133,000
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $13,185 - $15,067	-91 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$131.46 - $151.04 $11,962 - $13,744	91 New	91 $14,000
Q4 2017 Feb 14, 2018	SELL	$121.17 - $134.75 $3,877 - $4,312	-32 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $3,634 - $3,960	32	32 $4,000

598

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.97B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.